Atlas Trials

Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer

Clinical trial NCT01198535 · TERMINATED

Trial details

NCT number
NCT01198535
Sponsor
National Cancer Institute (NCI)
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Colon Mucinous AdenocarcinomaColon Signet Ring Cell AdenocarcinomaRectal Mucinous AdenocarcinomaRectal Signet Ring Cell AdenocarcinomaRecurrent Colon CarcinomaRecurrent Rectal CarcinomaStage IVA Colon CancerStage IVA Rectal CancerStage IVB Colon CancerStage IVB Rectal Cancer
Start date
2010-09-01
Primary completion
2012-07-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.